Status | Study |
Recruiting |
Study Name: TGF-(Beta) and Susceptibility to RSV Condition: Respiratory Syncytial Virus Asthma Date: 2010-10-19 |
Completed |
Study Name: Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee Condition: Osteoarthritis, Knee Date: 2010-10-13 Interventions: Biological: TissueGene-C Singl |
Completed |
Study Name: Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer Condition: Lung Neoplasm Carcinoma, Bronchogenic Date: 2010-01-27 Interventions: Biological: Lucanix Monthly intradermal injections of four irradiated allogeneic TGF-beta2 antisense gen |
Completed |
Study Name: Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma) Condition: Renal Cell Carcinoma Date: 2009-06-17 Interventions: Drug: Anti-Transforming Growth Factor-beta (GC 1008) |
Completed |
Study Name: Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer Condition: Breast Cancer Colorectal Cancer Head and Neck Cancer Date: 2009-05-09 Interventions: Procedure: venipuncture Venipu |
Active, not recruiting |
Study Name: Her2 and TGFBeta CTLs in Treatment of Her2 Positive Malignancy Condition: HER2 Positive Malignancies Date: 2009-04-24 Interventions: Biological: TGFBeta resistant HER2/EBV-CTLs Each patient w |
Completed |
Study Name: Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2 Condition: Pancreatic Neoplasms Melanoma Colorectal Neoplasms Date: 2009-02-12 Interventions: Drug: AP 12009 Initial scheme: AP 12009 (trabedersen), dos |
Completed |
Study Name: Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers Condition: Healthy Date: 2008-04-07 Interventions: Drug: P144 cream P144 cream wi |
Completed |
Study Name: Effect of Montelukast on the Expression and Variation of TGF-β for Children With Mild Persistent Asthma Condition: Asthma Date: 2007-09-27 Interventions: Drug: montelukast montelukast 5-mg chewable tablet with matching placebo once daily in the evening at be |
Completed |
Study Name: Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma Condition: Glioblastoma Anaplastic Astrocytoma Date: 2007-02-05 Interventions: Drug: AP 12009 10 µM 10 & |